These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32583448)

  • 1. Unequal Effects of Myosin 5B Mutations in Liver and Intestine Determine the Clinical Presentation of Low-Gamma-Glutamyltransferase Cholestasis.
    van IJzendoorn SCD; Li Q; Qiu YL; Wang JS; Overeem AW
    Hepatology; 2020 Oct; 72(4):1461-1468. PubMed ID: 32583448
    [No Abstract]   [Full Text] [Related]  

  • 2. MYO5B mutations cause cholestasis with normal serum gamma-glutamyl transferase activity in children without microvillous inclusion disease.
    Gonzales E; Taylor SA; Davit-Spraul A; Thébaut A; Thomassin N; Guettier C; Whitington PF; Jacquemin E
    Hepatology; 2017 Jan; 65(1):164-173. PubMed ID: 27532546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYO5B and bile salt export pump contribute to cholestatic liver disorder in microvillous inclusion disease.
    Girard M; Lacaille F; Verkarre V; Mategot R; Feldmann G; Grodet A; Sauvat F; Irtan S; Davit-Spraul A; Jacquemin E; Ruemmele F; Rainteau D; Goulet O; Colomb V; Chardot C; Henrion-Caude A; Debray D
    Hepatology; 2014 Jul; 60(1):301-10. PubMed ID: 24375397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal diagnosis of microvillus inclusion disease.
    Chen CP; Su YN; Chern SR; Wu PC; Wang W
    Taiwan J Obstet Gynecol; 2011 Sep; 50(3):399-400. PubMed ID: 22030065
    [No Abstract]   [Full Text] [Related]  

  • 5. Microvilli as markers of disordered apical-membrane trafficking and assembly: bowel and liver.
    Thompson RJ; Knisely AS
    Hepatology; 2014 Jul; 60(1):34-6. PubMed ID: 24668851
    [No Abstract]   [Full Text] [Related]  

  • 6. Editing Myosin VB Gene to Create Porcine Model of Microvillus Inclusion Disease, With Microvillus-Lined Inclusions and Alterations in Sodium Transporters.
    Engevik AC; Coutts AW; Kaji I; Rodriguez P; Ongaratto F; Saqui-Salces M; Medida RL; Meyer AR; Kolobova E; Engevik MA; Williams JA; Shub MD; Carlson DF; Melkamu T; Goldenring JR
    Gastroenterology; 2020 Jun; 158(8):2236-2249.e9. PubMed ID: 32112796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYO5B Pathogenic Variants Found to Cause Intestinal Symptoms Without Microvillus Inclusion Disease in a Child Who Previously Underwent Liver Transplantation for PFIC-like Cholestasis.
    Jarasvaraparn C; He M; Granadillo JL; Kulkarni S; Stoll J; Liss K
    J Pediatr Gastroenterol Nutr; 2021 Jan; 72(1):e22-e24. PubMed ID: 32459745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two cases of microvillus inclusion disease caused by MYO5B deficiency with prenatal abnormalities.
    Lu J; Qi Y; Ding H; Yin A
    Prenat Diagn; 2022 Jan; 42(1):136-140. PubMed ID: 34816459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The zebrafish goosepimples/myosin Vb mutant exhibits cellular attributes of human microvillus inclusion disease.
    Sidhaye J; Pinto CS; Dharap S; Jacob T; Bhargava S; Sonawane M
    Mech Dev; 2016 Nov; 142():62-74. PubMed ID: 27497746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic signatures of myosin-5B, the motor involved in microvillus inclusion disease.
    Heissler SM; Chinthalapudi K; Sellers JR
    J Biol Chem; 2017 Nov; 292(44):18372-18385. PubMed ID: 28882893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYO5B mutations in patients with microvillus inclusion disease presenting with transient renal Fanconi syndrome.
    Golachowska MR; van Dael CM; Keuning H; Karrenbeld A; Hoekstra D; Gijsbers CF; Benninga MA; Rings EH; van Ijzendoorn SC
    J Pediatr Gastroenterol Nutr; 2012 Apr; 54(4):491-8. PubMed ID: 22441677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview and online registry of microvillus inclusion disease patients and their MYO5B mutations.
    van der Velde KJ; Dhekne HS; Swertz MA; Sirigu S; Ropars V; Vinke PC; Rengaw T; van den Akker PC; Rings EH; Houdusse A; van Ijzendoorn SC
    Hum Mutat; 2013 Dec; 34(12):1597-605. PubMed ID: 24014347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features and MYO5B mutations of a family affected by microvillus inclusion disease].
    Cheng Y; Liang H; Cai NL; Guo L; Huang YG; Song YZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Sep; 19(9):968-974. PubMed ID: 28899465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phenotypic and genetic analysis of a family affected with microvillus inclusion disease].
    Mao M; Guo L; Zhang Z; Wang B; Huang S; Song Y; Chen F; Wen W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Dec; 33(6):792-796. PubMed ID: 27984607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microvillous atrophy: atypical presentations.
    Perry A; Bensallah H; Martinez-Vinson C; Berrebi D; Arbeille B; Salomon J; Goulet O; Marinier E; Drunat S; Samson-Bouma ME; Gérard B; Hugot JP
    J Pediatr Gastroenterol Nutr; 2014 Dec; 59(6):779-85. PubMed ID: 25111220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvillus inclusion disease with novel MYO5B pathogenic variants.
    Kwon R; Huang J; Oshima K; Warren M; Voltaggio L; Wang Y; Montgomery EA; Hutchings D
    Histopathology; 2021 Jul; 79(1):119-121. PubMed ID: 33544913
    [No Abstract]   [Full Text] [Related]  

  • 17. Myosin Vb uncoupling from RAB8A and RAB11A elicits microvillus inclusion disease.
    Knowles BC; Roland JT; Krishnan M; Tyska MJ; Lapierre LA; Dickman PS; Goldenring JR; Shub MD
    J Clin Invest; 2014 Jul; 124(7):2947-62. PubMed ID: 24892806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvillus inclusion disease: loss of Myosin vb disrupts intracellular traffic and cell polarity.
    Thoeni CE; Vogel GF; Tancevski I; Geley S; Lechner S; Pfaller K; Hess MW; Müller T; Janecke AR; Avitzur Y; Muise A; Cutz E; Huber LA
    Traffic; 2014 Jan; 15(1):22-42. PubMed ID: 24138727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apical Membrane Alterations in Non-intestinal Organs in Microvillus Inclusion Disease.
    Schlegel C; Weis VG; Knowles BC; Lapierre LA; Martin MG; Dickman P; Goldenring JR; Shub MD
    Dig Dis Sci; 2018 Feb; 63(2):356-365. PubMed ID: 29218485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myosin 5b loss of function leads to defects in polarized signaling: implication for microvillus inclusion disease pathogenesis and treatment.
    Kravtsov D; Mashukova A; Forteza R; Rodriguez MM; Ameen NA; Salas PJ
    Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(10):G992-G1001. PubMed ID: 25258405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.